206 related articles for article (PubMed ID: 27446843)
1. Adding Water to the Mill: Olmesartan-Induced Collagenous Sprue-A Case Report and Brief Literature Review.
Desruisseaux C; Bensoussan M; Désilets E; Tran HK; Arcand R; Poirier G; Wisniewski A; Manière T
Can J Gastroenterol Hepatol; 2016; 2016():4837270. PubMed ID: 27446843
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug.
Nielsen JA; Steephen A; Lewin M
World J Gastroenterol; 2013 Oct; 19(40):6928-30. PubMed ID: 24187471
[TBL] [Abstract][Full Text] [Related]
3. Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
Kulai T; Arnason T; MacIntosh D; Igoe J
Can J Gastroenterol Hepatol; 2016; 2016():6091571. PubMed ID: 27446852
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan-induced enteropathy treated with budesonide.
Kempenaers S; Bogaert J; De Maeyer M; Van Hauthem P; Ramael M; Schoeters P
Acta Gastroenterol Belg; 2019; 82(2):319-321. PubMed ID: 31314195
[TBL] [Abstract][Full Text] [Related]
5. New Onset Villous Atrophy in a Patient With Celiac Disease.
Cartee AK; Reyes Genere JP; Oxentenko AS
Gastroenterology; 2018 Oct; 155(4):988-989. PubMed ID: 30025705
[No Abstract] [Full Text] [Related]
6. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].
Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI
An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
Choi EY; McKenna BJ
Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
[TBL] [Abstract][Full Text] [Related]
8. Olmesartan-Induced Enteropathy.
Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
[TBL] [Abstract][Full Text] [Related]
9. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.
Burbure N; Lebwohl B; Arguelles-Grande C; Green PH; Bhagat G; Lagana S
Hum Pathol; 2016 Apr; 50():127-34. PubMed ID: 26997446
[TBL] [Abstract][Full Text] [Related]
10. Olmesartan Associated Enteropathy: Usefulness of Video Capsule Endoscopy in a Case With Doubtful Upper Endoscopic/Histological Picture.
Abbruzzi F; Loconte I; Carparelli S; Ierardi E; Di Leo A; Principi M
Curr Drug Saf; 2020; 15(1):65-68. PubMed ID: 31549594
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury secondary to diarrhea caused by "sprue-like" enteropathy associated with olmesartan.
Roca-Argente L; Diaz-Jaime FC; López-Romero LC; Manzur-Aguilar Y; Moll-Guillem JL; Del Val-Antoñana A; Hernandez-Jaras J
Nefrologia; 2017; 37(5):548-550. PubMed ID: 28027786
[No Abstract] [Full Text] [Related]
12. Olmesartan-associated sprue-like enteropathy: An emerging cause of drug-induced chronic diarrhea.
Solano-Iturri G; García-Jiménez N; Solano-Iturri JD; Blanco-Sampascual S
Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):71-72. PubMed ID: 28291561
[No Abstract] [Full Text] [Related]
13. Olmesartan: sprue-like enteropathy.
Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
[TBL] [Abstract][Full Text] [Related]
14. An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
Naik DK; Martelli MG; Gonzalo DH; Sharma AK; Pannu D
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370634
[TBL] [Abstract][Full Text] [Related]
15. [Diarrhoea and malabsorption due to olmesartan use].
van Beurden YH; Nijeboer P; Janssen J; Verbeek WH; Mulder CJ
Ned Tijdschr Geneeskd; 2014; 158():A7370. PubMed ID: 24780574
[TBL] [Abstract][Full Text] [Related]
16. Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
Gonakoti S; Khullar S; Rajkumar A
Am J Case Rep; 2019 Jan; 20():111-116. PubMed ID: 30683835
[TBL] [Abstract][Full Text] [Related]
17. [Three cases of severe chronic diarrhea with a rare cause and a simple therapy].
Rommel KP; Schneider E; Witschel I; Halm U; Zachäus M
Internist (Berl); 2018 Sep; 59(9):961-966. PubMed ID: 29637237
[TBL] [Abstract][Full Text] [Related]
18. Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report.
Makri A; Florentin M; Elisaf MS; Liamis G
Curr Drug Saf; 2019; 14(3):238-241. PubMed ID: 30848210
[TBL] [Abstract][Full Text] [Related]
19. An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
Imperatore N; Tortora R; Capone P; Caporaso N; Rispo A
Scand J Gastroenterol; 2016 Mar; 51(3):378-80. PubMed ID: 26554620
[No Abstract] [Full Text] [Related]
20. Olmesartan-induced enteropathy.
Onteddu NK; Pulivarthi VSKK; Ginnavaram M; Kedika R
BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
